{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:19:03Z","timestamp":1786997943539,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001323","name":"Poliomyelitis Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001323","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.vaccine.2013.06.089","type":"journal-article","created":{"date-parts":[[2013,7,15]],"date-time":"2013-07-15T23:30:41Z","timestamp":1373931041000},"page":"4177-4182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines"],"prefix":"10.1016","volume":"31","author":[{"given":"N.","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.R.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Niezgoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Ellison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.H.","family":"Nel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.06.089_bib0005","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.vaccine.2008.09.054","article-title":"Rabies control in rural Africa: evaluating strategies for effective domestic dog vaccination","volume":"27","author":"Kaare","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0010","first-page":"161","article-title":"Emergence of lyssaviruses in the old world: the case of Africa","volume":"315","author":"Nel","year":"2007","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0015","series-title":"World Health Organ Tech Rep Ser","first-page":"931","author":"WHO Expert Consultation on rabies","year":"2005"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0020","doi-asserted-by":"crossref","first-page":"e515","DOI":"10.1371\/journal.pntd.0000515","article-title":"Novel vaccines to human rabies","volume":"3","author":"Ertl","year":"2009","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0025","first-page":"61","article-title":"Meeting the rabies control challenge in South Africa","volume":"4","author":"Nel","year":"2009","journal-title":"Microbe"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2334-1-23","article-title":"Field trial with oral vaccination of dogs against rabies in the Philippines","volume":"1","author":"Estrada","year":"2001","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0035","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1016\/j.vaccine.2006.12.054","article-title":"The safety and efficacy of the oral rabies vaccine SAG2 in Indian stray dogs","volume":"25","author":"Cliquet","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0040","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1371\/journal.pntd.0000626","article-title":"The feasibility of canine rabies elimination in africa: dispelling doubts with data","volume":"4","author":"Lembo","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.virusres.2005.03.012","article-title":"Status of oral rabies vaccination in wild carnivores in the United States","volume":"111","author":"Slate","year":"2005","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0050","first-page":"185","article-title":"Elimination of terrestrial rabies in western European countries","volume":"119","author":"Cliquet","year":"2005","journal-title":"Dev Biol"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0055","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1371\/journal.pntd.0000549","article-title":"Oral rabies vaccination in North America: Opportunities, Complexities, and Challenges","volume":"13","author":"Slate","year":"2009","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0060","first-page":"459","article-title":"SAG-2 oral rabies vaccine","volume":"60","author":"Schumacher","year":"1993","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0065","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0264-410X(95)00244-U","article-title":"Immunogenicity, efficacy and safety of an oral rabies vaccine (SAG-2) in dogs","volume":"14","author":"Fekadu","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0070","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0264-410X(96)00114-4","article-title":"Safety study of the SAG2 rabies virus mutant in several non-target species with a view to its future use for the immunization of foxes in Europe","volume":"14","author":"Masson","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0075","doi-asserted-by":"crossref","first-page":"420","DOI":"10.7589\/0090-3558-38.2.420","article-title":"Oral efficacy of an attenuated rabies vaccine in skunks and raccoons","volume":"38","author":"Hanlon","year":"2002","journal-title":"J Wildlife Dis"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0080","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0264-410X(98)00233-3","article-title":"Efficacy of SAG-2 oral rabies vaccine in two species of jackal (Canis adustus and Canis mesomelas)","volume":"17","author":"Bingham","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0085","first-page":"73","article-title":"Seroconversion in captive African wild dogs (Lycaon pictus) follwing administration of a chicken head bait\/SAG-2 oral rabies vaccine combination","volume":"70","author":"Knobel","year":"2003","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0090","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00705-009-0408-7","article-title":"Analysis of vaccine-virus-associated rabies cases in red foxes (Vulpes vulpes) after oral vaccination campaigns in Germany and Austria","volume":"154","author":"M\u00fcller","year":"2009","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0095","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1348-0421.2008.00085.x","article-title":"Genetic stability (in vivo) of the attenuated oral rabies virus vaccine SAD B19","volume":"53","author":"Beckert","year":"2009","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0100","series-title":"Rabies","first-page":"365","article-title":"Control of wildlife rabies","author":"Wandeler","year":"1988"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.7589\/0090-3558-44.1.71","article-title":"ERA vaccine-derived cases of rabies in wildlife and domestic animals in Ontario, Canada, 1989\u20132004","volume":"44","author":"Fehlner-Gardiner","year":"2008","journal-title":"J Wildl Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2013.06.089_bib0110","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00705-009-0408-7","article-title":"Vaccine virus associated rabies cases in red foxes (Vulpes vulpes) after oral rabies vaccination campaigns in Germany and Austria","volume":"154","author":"M\u00fcller","year":"2009","journal-title":"Arch Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2013.06.089_bib0115","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1056\/NEJMoa010560","article-title":"Human infection due to recombinant vaccinia-rabies glycoprotein virus","volume":"345","author":"Rupprecht","year":"2001","journal-title":"N Engl J Med"},{"issue":"240","key":"10.1016\/j.vaccine.2013.06.089_bib0120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2460\/javma.240.2.163","article-title":"National surveillance for human and pet contact with oral rabies vaccine baits, 2001\u20132009","volume":"15","author":"Roess","year":"2012","journal-title":"J Am Vet Assoc"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0125","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1016\/j.vaccine.2009.09.030","article-title":"Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine","volume":"27","author":"Henderson","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0130","first-page":"1199","article-title":"Canine adenovirus type 2-induced immunity to two canine adenoviruses in pups with maternal antibody","volume":"36","author":"Appel","year":"1975","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0135","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/S0264-410X(02)00344-4","article-title":"Vaccination of puppies born to immune dams with a canine adenovirus-based vaccine protects against canine distemper virus challenge","volume":"20","author":"Fischer","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0140","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.virol.2006.07.037","article-title":"A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice","volume":"356","author":"Li","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0145","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.micinf.2005.11.007","article-title":"Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein","volume":"8","author":"Hu","year":"2006","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0150","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.vaccine.2007.11.029","article-title":"Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies","volume":"26","author":"Zhang","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0155","first-page":"543","article-title":"Pathogenicity of low-virulence strains of two canine adenoviruses","volume":"34","author":"Appel","year":"1973","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0160","first-page":"1","article-title":"An acute virus disease with liver lesions in dogs (hepatitis contagiosa canis)","volume":"69","author":"Rubarth","year":"1947","journal-title":"Acta Pathol Microbiol Immunol Scand Suppl"},{"issue":"1","key":"10.1016\/j.vaccine.2013.06.089_bib0165","first-page":"37","article-title":"Seroprevalence of canine adenovirus (CAV) infection in Kars dogs in Turkey","volume":"20","author":"Yildirim","year":"2009","journal-title":"Y. Y. U. Vet Fak Derg"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0170","first-page":"1687","article-title":"A comparison of the pathogenesis and antigenicity of infectious canine hepatitis virus and the A26\/61 virus strain (Toronto)","volume":"156","author":"Swango","year":"1970","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0175","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/vr.154.15.457","article-title":"Serum antibody titers to canine parvovirus, adenovirus and distemper virus in dogs in the UK which have not been vaccinated for at least three years","volume":"154","author":"Bohm","year":"2004","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0180","first-page":"563","article-title":"Prevalence of respiratory viruses isolated from dogs in Thailand during 2008\u20132009","volume":"4","author":"Posuwan","year":"2010","journal-title":"Biomedicine"},{"issue":"2","key":"10.1016\/j.vaccine.2013.06.089_bib0185","doi-asserted-by":"crossref","first-page":"474","DOI":"10.7589\/0090-3558-46.2.474","article-title":"Serosurvey for canine distemper virus, canine adenovirus, Leptospira interrogans and Toxoplasma gondii in free-ranging canids in Scandinavia and Svalbard","volume":"46","author":"Akerstedt","year":"2010","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0190","doi-asserted-by":"crossref","first-page":"10780","DOI":"10.1128\/JVI.77.20.10780-10789.2003","article-title":"Oral vaccination of mice with adenoviral vectors is not impaired by pre-existing immunity to the vaccine carrier","volume":"77","author":"Xiang","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0195","series-title":"Laboratory techniques in rabies","first-page":"181","article-title":"A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus neutralizing antibody","author":"Smith","year":"1996"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0200","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vetmic.2006.04.009","article-title":"Canine vaccination\u2014providing broader benefits for disease control","volume":"117","author":"Cleaveland","year":"2006","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0205","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1044-5773(05)80016-2","article-title":"Molecular epidemiology of rabies in the United States","volume":"6","author":"Smith","year":"1995","journal-title":"Semin Virol"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.virusres.2005.03.006","article-title":"Overview of rabies in the Americas","volume":"111","author":"Belotto","year":"2005","journal-title":"Virus Res"},{"issue":"9","key":"10.1016\/j.vaccine.2013.06.089_bib0215","first-page":"1460","article-title":"Serum antibody response to canine parvovirus, canine adenovirus 1 and canine distemper virus in dogs with known status of immunization: study of dogs in Sweden","volume":"49","author":"Olsen","year":"1988","journal-title":"Am J Vet Res"},{"issue":"2","key":"10.1016\/j.vaccine.2013.06.089_bib0220","first-page":"123","article-title":"Antiviral antibodies in dogs in the Netherlands","volume":"24","author":"Osterhaus","year":"1977","journal-title":"J Vet Med B"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0225","doi-asserted-by":"crossref","first-page":"86","DOI":"10.7589\/0090-3558-30.1.86","article-title":"Serologic survey of Gaint Pandas (Ailuropoda melanoleuca) and domestic dogs and cats in Wolong Reserve, China","volume":"30","author":"Mainka","year":"1994","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0230","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1751-0813.2005.tb15634.x","article-title":"Prevalence of serum antibodies to canine adenovirus and canine herpesvirus in the European red fox (Vulpes vulpes) in Australia","volume":"83","author":"Robinson","year":"2005","journal-title":"Aust Vet J"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0235","first-page":"251","article-title":"Presence of antibodies to canine distemper virus, canine parvovirus and canine adenovirus type 1 in free-ranging jackals (Canis adustus and Canis mesomelas) in Zimbabwe","volume":"66","author":"Spencer","year":"1999","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0240","doi-asserted-by":"crossref","first-page":"64","DOI":"10.7589\/0090-3558-28.1.64","article-title":"Prerequisites for oral immunization of free-ranging raccoons (Procyon lotor) with a recombinant rabies virus vaccine: study site ecology and bait system development","volume":"28","author":"Hable","year":"1992","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0245","first-page":"169","article-title":"Oral administration of an attenuated strain of canine adenovirus (type2) to raccoons, foxes, skunk and mongoose","volume":"49","author":"Sumner","year":"1988","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0250","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/vr.155.5.135","article-title":"Antibodies to selected pathogens in free-ranging terrestrial carnivores and marine mammals in Canada","volume":"155","author":"Philippa","year":"2004","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0255","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/030098589202900604","article-title":"Experimental oral administration of canine adenovirus (type2) to raccoons (Procyon lotori)","volume":"29","author":"Hamir","year":"1992","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2013.06.089_bib0260","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2172-9-57","article-title":"Potential effect of prior raccoonpox virus infection in raccoons on vaccinia-based rabies immunization","volume":"9","author":"Root","year":"2008","journal-title":"BMC Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13008992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13008992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T05:12:32Z","timestamp":1563426752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13008992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":52,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0264410X13008992"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.089","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}